Skip to main navigation Skip to search Skip to main content

Tsg101 chaperone function revealed by HIV-1 assembly inhibitors

  • Madeleine Strickland
  • , Lorna S. Ehrlich
  • , Susan Watanabe
  • , Mahfuz Khan
  • , Marie Paule Strub
  • , Chi Hao Luan
  • , Michael D. Powell
  • , Jonathan Leis
  • , Nico Tjandra
  • , Carol A. Carter
  • National Institutes of Health
  • Stony Brook University
  • Morehouse School of Medicine
  • Northwestern University

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

HIV-1 replication requires Tsg101, a component of cellular endosomal sorting complex required for transport (ESCRT) machinery. Tsg101 possesses an ubiquitin (Ub) E2 variant (UEV) domain with a pocket that can bind PT/SAP motifs and another pocket that can bind Ub. The PTAP motif in the viral structural precursor polyprotein, Gag, allows the recruitment of Tsg101 and other ESCRTs to virus assembly sites where they mediate budding. It is not known how or even whether the UEV Ub binding function contributes to virus production. Here, we report that disruption of UEV Ub binding by commonly used drugs arrests assembly at an early step distinct from the late stage involving PTAP binding disruption. NMR reveals that the drugs form a covalent adduct near the Ub-binding pocket leading to the disruption of Ub, but not PTAP binding. We conclude that the Ub-binding pocket has a chaperone function involved in bud initiation.

Original languageEnglish
Article number1391
JournalNature Communications
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Dive into the research topics of 'Tsg101 chaperone function revealed by HIV-1 assembly inhibitors'. Together they form a unique fingerprint.

Cite this